DIBAQ DIPROTEG SA

Their core work

DIBAQ DIPROTEG SA is a Spanish private company operating in the aquaculture and animal nutrition industry, with a specialization in feed and nutritional products for Mediterranean fish species, particularly seabream and seabass. In EU-funded research, they contribute as an industry partner, bringing hands-on knowledge of feed formulation, production-level technical performance, and commercial market realities. Their participation in MedAID shows engagement across the full value chain — from fish genetics and integrated health management to business development, marketing strategies, and sector governance. They represent the "end-user industry" role in research consortia: grounding scientific development in market applicability and commercial viability.

What they specialise in

How they've shifted over time

Both of DIBAQ's H2020 projects started in 2017, so there is no meaningful chronological shift within their H2020 portfolio — the early and recent keyword sets are identical because the data reflects a single cohort of activity. Their known focus during this period spans technical fish performance, nutrition, genetics, and health on one side, and commercial aspects — business development, marketing, and sector image — on the other. Without post-2021 project data, it is impossible to say whether they deepened their technical research involvement, shifted toward the commercial/governance side, or exited EU research activity altogether after MedAID ended in 2021.

With both projects anchored in 2017 and no newer activity visible in this dataset, DIBAQ's trajectory within EU research is unclear — a future collaborator should verify whether the company has continued engaging in Horizon Europe calls or returned to purely commercial operations.

How they like to work

DIBAQ has participated exclusively as a consortium partner — they have never led or coordinated an H2020 project. Despite this, their network footprint is substantial: 46 unique consortium partners across 15 countries from just two projects, suggesting they joined large, well-connected research consortia rather than small focused ones. This profile is typical of industry partners who are brought in to validate commercial relevance and provide market access, rather than to drive the research agenda.

DIBAQ has built connections with 46 distinct partners across 15 countries through two projects, which is a notably wide network for an organization with such limited project history. Their engagement in pan-European aquaculture consortia — likely including research institutes, universities, and other aquaculture producers — gives them access to a broad scientific and industry community around Mediterranean fish farming.

What sets them apart

DIBAQ brings something most research partners cannot: real industrial-scale knowledge of aquaculture feed formulation and the commercial pressures facing Mediterranean fish farmers. As a large private company (non-SME) in a sector dominated by SMEs and research institutes in EU projects, they carry weight as a credible market validator. For a consortium building around aquaculture innovation, DIBAQ represents a direct industry channel to production-level adoption and market entry in southern Europe.

Highlights from their portfolio

• MedAID
  The most substantive project in their portfolio — a multi-year RIA running 2017–2021 covering the full Mediterranean aquaculture value chain from genetics and health to marketing and governance, with EUR 114,625 in EC funding for DIBAQ's contribution.
• BIOSEA
  A BBI-RIA project targeting novel aquatic biomass valorization for food and feed, signaling DIBAQ's interest in next-generation ingredient streams beyond conventional aquafeed formulations.